Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALQA

Alliqua Biomedical (ALQA) Stock Price, News & Analysis

Alliqua Biomedical logo

About Alliqua Biomedical Stock (NASDAQ:ALQA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$3.23
52-Week Range
N/A
Volume
371,516 shs
Average Volume
114,400 shs
Market Capitalization
$13.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alliqua BioMedical, Inc. develops, manufactures, and markets high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It also provides contract manufacturing services to the OEM market. The company is headquartered in Langhorne, Pennsylvania.

Receive ALQA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliqua Biomedical and its competitors with MarketBeat's FREE daily newsletter.

ALQA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

ALQA Stock Analysis - Frequently Asked Questions

Alliqua Biomedical Inc (NASDAQ:ALQA) posted its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of ($2.70) by $3.20. The firm had revenue of $5.50 million for the quarter, compared to the consensus estimate of $5.38 million. Alliqua Biomedical had a negative trailing twelve-month return on equity of 71.73% and a negative net margin of 230.50%.

Alliqua Biomedical's stock reverse split before market open on Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliqua Biomedical investors own include Palatin Technologies (PTN), ContraVir Pharmaceuticals (CTRV), Argos Therapeutics (ARGSQ), Consolidated Water (CWCO), Bristol-Myers Squibb (BMY), Biopharmx (BPMX) and Ritter Pharmaceuticals (RTTR).

Company Calendar

Last Earnings
8/09/2016
Today
5/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ALQA
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,420,000.00
Net Margins
-230.50%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.22 million
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$13.46 million
Optionable
Not Optionable
Beta
2.03
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ALQA) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners